Telome Health to launch saliva-based TeloTest
Telome Health, Inc., developer of the TeloTest diagnostic test that measures average telomere length, has planned to launch saliva-based TeloTest in the first quarter of 2013.
Study finds link between telomere shortening and heart attack risk
A recent study has once again found a possible link between telomere shortening and an increased risk of disease.
Biotech Company Life Length Partners with US Firm to Provide Public Telomeres Testing Nationwide.
In a Thursday press release Life Length, a leading Spain-based biotechnology company specializing in the field of telomeres research technology, announced an agreement with Age Diagnostics Laboratories, Inc (“ADL”) to offer telomere testing nationwide in the US to both doctors and patients. This partnership will provide a location in the US where blood and tissue samples will be collected before being relayed to Life Length’s location in Europe for analysis.
Telome Health, Inc. Launches First Trial in Telomeres Testing
Telome Health, Inc. (THINC), a biotechnology firm based in Menlo Park, CA has launched the beginning phase of a research study that will measure and analyze age-based average telomere lengths of Bay Area residents.
Study shows that short telomeres may be linked with cancer development
A new prospective study suggests that people who have white blood cells with shorter telomeres are at a higher risk of developing cancer. This research is the first of its kind to address the direct connection between telomeres and cancer. In what is known as the Bruneck Study, the telomeres of 787 subjects in England, Austria and Italy were monitored over the course of ten years.
Follow us on Twitter 
Explore our FaceBook page
On Google +